Tyenne (tocilizumab-aazg) Injection, 400 mg/20 mL (20 mg/mL), 20 mL vial, Rx Only, Manufactured by Fresenius Kabi USA, LLC, Lake Zurich, Illinois…
Why it was recalled
Presence of particulate matter:An internal investigation at the firm found the product to contain glass particles.
What to do
The recall is ongoing. Follow the firm and FDA instructions.
Affected products and identifiers
Lot: 16UI07, Exp 08/31/2028 — 4,643 20mL-vials
Record details
Fresenius Kabi USA, LLC — Nationwide in the USA